Filing Details
- Accession Number:
- 0001237899-12-000087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-27 17:54:03
- Reporting Period:
- 2012-11-26
- Filing Date:
- 2012-11-27
- Accepted Time:
- 2012-11-27 17:54:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1225470 | A Charles Baker | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-11-26 | 1,100 | $9.17 | 10,690 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-26 | 1,100 | $175.14 | 9,590 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-11-26 | 6,565 | $9.17 | 16,155 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-26 | 6,565 | $174.46 | 9,590 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-11-26 | 5,035 | $9.17 | 14,625 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-26 | 5,035 | $173.63 | 9,590 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-11-26 | 1,200 | $9.17 | 10,790 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-26 | 1,200 | $172.65 | 9,590 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-11-26 | 1,100 | $9.17 | 10,690 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-26 | 1,100 | $171.45 | 9,590 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-11-26 | 1,100 | $0.00 | 1,100 | $9.17 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-11-26 | 6,565 | $0.00 | 6,565 | $9.17 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-11-26 | 5,035 | $0.00 | 5,035 | $9.17 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-11-26 | 1,200 | $0.00 | 1,200 | $9.17 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-11-26 | 1,100 | $0.00 | 1,100 | $9.17 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,900 | 2015-01-03 | No | 4 | M | Direct | |
| 7,335 | 2015-01-03 | No | 4 | M | Direct | |
| 2,300 | 2015-01-03 | No | 4 | M | Direct | |
| 1,100 | 2015-01-03 | No | 4 | M | Direct | |
| 0 | 2015-01-03 | No | 4 | M | Direct |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 26, 2012 at prices ranging from $175.00 to $175.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price.
- Represents volume-weighted average price of sales of 6,565 shares of Company stock on November 26, 2012 at prices ranging from $174.07 to $174.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price.
- Represents volume-weighted average price of sales of 5,035 shares of Company stock on November 26, 2012 at prices ranging from $173.08 to $173.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price.
- Represents volume-weighted average price of sales of 1,200 shares of Company stock on November 26, 2012 at prices ranging from $172.06 to $172.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price.
- Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 26, 2012 at prices ranging from $171.01 to $171.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
Billionaire Hedge Funds
